stockrow
Friday 6 November 2026
Export IQV’s income statement to Excel — free account
IQVIA Holdings Inc.
IQV Healthcare Diagnostics & Research
IQVIA Holdings Inc.’s revenue for fiscal 2025 (year ended December 2025) was $16.3 billion, up 5.87% from fiscal 2024.
- Revenue
- +8.00%
- EPS
- +10.2%
- Free cash flow
- −21.3%
- Total debt
- +7.42%
Quarter to September 2026, against a year earlier
269.78
4.90
+1.85%
Follow IQV
Alert me
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
28.43 | 25.92 | 31.09 | 35.09 | 55.87 | 122.72 | 157.66 | 91.47 | 15.78 | 44.99 |
Piotroski F-Score |
4 | 5 | 8 | 7 | 6 | 6 | 5 | 6 | 5 | 5 |
Altman Z-Score |
2.05 | 2.13 | 2.25 | 2.14 | 2.59 | 1.78 | 1.72 | 1.55 | 1.45 | 0.97 |
P/S ratio |
2.38 | 2.31 | 2.83 | 2.65 | 3.89 | 3.02 | 2.72 | 2.27 | 2.24 | 1.68 |
P/FCF ratio |
18.23 | 16.66 | 28.23 | 24.11 | 23.46 | 25.52 | 36.10 | 29.77 | 36.15 | 16.48 |
Altman Z″-Score (non-manufacturers) |
1.14 | 1.32 | 1.16 | 1.06 | 0.89 | 0.87 | 0.80 | 0.90 | 0.98 | 1.07 |
Beneish M-Score |
(2.59) | (2.75) | (2.49) | (2.61) | (2.75) | (2.88) | (2.65) | (2.60) | (2.37) | (1.57) |
P/Operating CF |
52.72 | 40.26 | 56.69 | 68.29 | 78.04 | 45.70 | 51.71 | 56.75 | 93.25 | 25.66 |
P/B ratio |
5.84 | 5.87 | 6.93 | 6.63 | 8.94 | 5.46 | 4.81 | 3.40 | 2.64 | 1.29 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
3.21 | 3.10 | 3.64 | 3.45 | 4.66 | 3.95 | 3.69 | 3.24 | 3.19 | 2.56 |
EV/EBITDA |
15.63 | 14.31 | 17.48 | 16.88 | 24.18 | 22.06 | 20.53 | 17.82 | 17.91 | 18.83 |
EV/Operating CF |
19.72 | 17.59 | 25.37 | 21.98 | 21.97 | 22.92 | 28.86 | 26.90 | 31.90 | 20.27 |
EV/FCF |
24.61 | 22.33 | 36.35 | 31.33 | 28.08 | 33.44 | 48.97 | 42.43 | 51.49 | 25.05 |
Quick Ratio |
0.67 | 0.73 | 0.76 | 0.77 | 0.78 | 0.96 | 0.90 | 0.96 | 1.00 | 1.10 |
Current Ratio |
0.75 | 0.84 | 0.86 | 0.89 | 0.91 | 1.12 | 1.05 | 1.10 | 1.13 | 1.23 |
Net Debt/EBITDA |
4.06 | 3.64 | 3.90 | 3.89 | 3.98 | 5.22 | 5.39 | 5.32 | 5.34 | 6.44 |
Debt/Assets |
52.51% | 51.98% | 51.25% | 50.31% | 49.11% | 51.02% | 50.08% | 48.81% | 44.73% | 33.95% |
Debt/Equity |
2.37 | 2.30 | 2.24 | 2.21 | 2.01 | 2.00 | 1.86 | 1.58 | 1.24 | 0.81 |
Asset Turnover |
0.57 | 0.58 | 0.58 | 0.58 | 0.56 | 0.48 | 0.48 | 0.46 | 0.44 | 0.54 |
Operating CF/Net income |
1.95 | 1.98 | 1.58 | 2.07 | 3.05 | 7.02 | 7.42 | 4.84 | 0.76 | 11.94 |
Capex/Depreciation |
(0.45) | (0.51) | (0.57) | (0.59) | (0.50) | (0.47) | (0.48) | (0.40) | (0.35) | (0.47) |
Interest Coverage |
2.99 | 3.29 | 2.94 | 4.32 | 3.71 | 1.76 | 1.74 | 1.79 | 1.92 | 4.00 |
| 21.42% | 22.55% | 22.87% | 18.48% | 15.68% | 4.45% | 2.89% | 3.41% | 14.93% | 1.69% | |
| 4.79% | 5.13% | 5.22% | 4.36% | 3.92% | 1.17% | 0.83% | 1.14% | 5.80% | 0.57% | |
ROIC |
6.75% | 7.56% | 6.76% | 6.54% | 5.22% | 2.70% | 2.86% | 2.72% | 2.38% | 2.43% |
Return on Tangible Assets |
(87.40%) | (231.53%) | (365.05%) | (1,678.46%) | 5,084.21% | 27.51% | 29.89% | 33.46% | 152.39% | 6.94% |
Average Days of Receivables |
76.69 | 76.77 | 83.14 | 74.98 | 68.64 | 79.24 | 86.84 | 86.34 | 80.66 | 93.25 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
12.26% | 12.93% | 13.70% | 14.37% | 14.16% | 15.75% | 15.64% | 16.48% | 16.72% | 14.91% |
Intangible Assets out of Total Assets |
0.72 | 0.71 | 0.73 | 0.74 | 0.74 | 0.73 | 0.76 | 0.79 | 0.81 | 0.81 |
Share Based Compensation of Revenue |
1.51% | 1.34% | 1.45% | 1.35% | 1.23% | 0.84% | 1.32% | 1.09% | 1.09% | 1.17% |
Graham Net Nets |
(0.44) | (0.42) | (0.35) | (0.38) | (0.26) | (0.38) | (0.43) | (0.50) | (0.51) | (0.79) |
Graham Number |
82.96 | 75.55 | 74.46 | 63.38 | 59.89 | 32.84 | 26.61 | 31.23 | 73.38 | 47.82 |
Earnings Yield |
3.52% | 3.86% | 3.22% | 2.85% | 1.79% | 0.81% | 0.63% | 1.09% | 6.34% | 2.22% |
Free Cash Flow Yield |
5.49% | 6.00% | 3.54% | 4.15% | 4.26% | 3.92% | 2.77% | 3.36% | 2.77% | 6.07% |
Revenue per Share |
94.88 | 84.97 | 81.52 | 76.81 | 72.49 | 59.38 | 56.83 | 51.11 | 44.55 | 45.71 |
Operating CF per Share |
15.44 | 14.98 | 11.69 | 12.05 | 15.37 | 10.24 | 7.26 | 6.16 | 4.45 | 5.77 |
Capex per Share |
(3.07) | (3.18) | (3.53) | (3.59) | (3.34) | (3.22) | (2.98) | (2.25) | (1.69) | (1.10) |
Free Cash Flow per Share |
12.37 | 11.80 | 8.16 | 8.45 | 12.03 | 7.02 | 4.28 | 3.90 | 2.76 | 4.67 |
Cash per Share |
12.45 | 10.17 | 8.14 | 6.98 | 7.72 | 9.94 | 4.61 | 4.60 | 4.61 | 8.30 |
Shareholders Equity per Share |
38.57 | 33.46 | 33.25 | 30.73 | 31.57 | 32.83 | 32.10 | 34.14 | 37.85 | 59.42 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
38.57 | 33.46 | 33.25 | 30.73 | 31.57 | 32.83 | 32.10 | 34.14 | 37.85 | 59.42 |
Free Cash Flow |
2,126.00 | 2,139.00 | 1,500.00 | 1,586.00 | 2,302.00 | 1,343.00 | 835.00 | 795.00 | 601.00 | 696.00 |
Working Capital |
(2,089.00) | (1,128.00) | (895.00) | (597.00) | (478.00) | 532.00 | 181.00 | 340.00 | 398.00 | 632.00 |
Capital Expenditures |
(528.00) | (577.00) | (649.00) | (674.00) | (640.00) | (616.00) | (582.00) | (459.00) | (369.00) | (164.00) |
Net Current Asset Value |
(17,065.00) | (15,003.00) | (14,973.00) | (14,591.00) | (13,884.00) | (13,194.00) | (12,862.00) | (11,721.00) | (11,059.00) | (9,011.00) |
EV/EBIT |
23.98 | 21.69 | 27.58 | 27.62 | 46.41 | 61.43 | 52.63 | 45.52 | 46.54 | 30.26 |
Capex to Sales |
0.03 | 0.04 | 0.04 | 0.05 | 0.05 | 0.05 | 0.05 | 0.04 | 0.04 | 0.02 |
Price to Operating Income |
17.76 | 16.18 | 21.42 | 21.26 | 38.77 | 46.89 | 38.80 | 31.94 | 32.67 | 19.91 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
2.19 | 2.12 | 2.19 | 2.15 | 2.58 | 2.71 | 2.65 | 2.65 | 2.42 | 0.86 |
Cash ROIC |
8.68% | 9.77% | 7.05% | 8.00% | 11.72% | 6.48% | 4.44% | 4.21% | 3.09% | 4.02% |
Accounts Receivable Turnover |
4.89 | 4.63 | 4.70 | 5.18 | 5.47 | 4.45 | 4.35 | 4.52 | 4.99 | 4.63 |
Accounts Payable Turnover |
2.93 | 2.77 | 2.83 | 2.98 | 3.19 | 2.82 | 3.04 | 5.16 | 22.03 | 24.04 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
125.84 | 134.06 | 133.49 | 129.01 | 117.85 | 136.90 | 125.60 | 124.17 | 18.65 | 19.22 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
3,333.50 | 3,326.50 | 3,186.50 | 2,784.50 | 2,537.50 | 2,552.00 | 2,550.50 | 2,303.50 | 1,942.50 | 1,470.50 |
Average Payables |
3,717.50 | 3,624.00 | 3,440.00 | 3,148.50 | 2,897.00 | 2,662.50 | 2,403.50 | 1,308.50 | 286.00 | 197.50 |
Average Assets |
28,421.50 | 26,790.00 | 26,009.00 | 25,013.00 | 24,626.50 | 23,907.50 | 22,900.00 | 22,703.00 | 22,032.50 | 12,567.00 |
Average Common Equity |
6,348.50 | 6,089.50 | 5,938.50 | 5,903.50 | 6,161.00 | 6,271.50 | 6,608.50 | 7,599.00 | 8,552.00 | 4,262.00 |
Columns are period end dates · fundamentals updated 2 Nov 2026